The effects of l-cysteine and N-acetyl-l-cysteine on homocysteine metabolism and haemostatic markers, and on cardiac and aortic histology in subchronically methionine-treated Wistar male rats

[1]  N. Deutz,et al.  Tolerance to increased supplemented dietary intakes of methionine in healthy older adults. , 2017, The American journal of clinical nutrition.

[2]  Y. Benazzoug,et al.  Plasma and Aorta Biochemistry and MMPs Activities in Female Rabbit Fed Methionine Enriched Diet and Their Offspring , 2017, Journal of nutrition and metabolism.

[3]  Karen H. Vousden,et al.  Serine and one-carbon metabolism in cancer , 2016, Nature Reviews Cancer.

[4]  E. Casiglia,et al.  Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial. , 2016, Journal of biological regulators and homeostatic agents.

[5]  B. Wolska,et al.  N-acetylcysteine reverses diastolic dysfunction and hypertrophy in familial hypertrophic cardiomyopathy. , 2015, American journal of physiology. Heart and circulatory physiology.

[6]  T. Dar,et al.  Protein N-homocysteinylation: From cellular toxicity to neurodegeneration. , 2015, Biochimica et biophysica acta.

[7]  K. Frazer,et al.  Brief Report: Oxidative Stress Mediates Cardiomyocyte Apoptosis in a Human Model of Danon Disease and Heart Failure , 2015, Stem cells.

[8]  R. Pawlak Is vitamin B12 deficiency a risk factor for cardiovascular disease in vegetarians? , 2015, American journal of preventive medicine.

[9]  Y. Kawamata,et al.  A 4-Week Toxicity Study of Methionine in Male Rats , 2015, International journal of toxicology.

[10]  D. Vasudevan,et al.  Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study. , 2015, Indian heart journal.

[11]  B. Kulah,et al.  Study on relationships among deep vein thrombosis, homocysteine & related B group vitamins , 2015, Pakistan journal of medical sciences.

[12]  Y. Turkoz,et al.  Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats. , 2014, World journal of gastroenterology.

[13]  Xiaoyan Wu,et al.  N-acetylcysteine reduces oxidative stress, nuclear factor-κB activity and cardiomyocyte apoptosis in heart failure , 2014, Molecular medicine reports.

[14]  X. Cai,et al.  Regulation of N-acetyl cysteine on gut redox status and major microbiota in weaned piglets. , 2014, Journal of animal science.

[15]  Z. Kopczyński,et al.  [Hyperhomocysteinemia in patients with cardiovascular disease]. , 2014, Postepy higieny i medycyny doswiadczalnej.

[16]  K. Toutouzas,et al.  The effect of hyperhomocysteinemia on aortic distensibility in healthy individuals. , 2013, Nutrition.

[17]  B. Banecki,et al.  Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke--pathogenic and therapeutic implications. , 2012, Acta biochimica Polonica.

[18]  Yingkang Shi,et al.  The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice. , 2012, Acta biochimica et biophysica Sinica.

[19]  Danmei Xu,et al.  Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies , 2012, Journal of Thrombosis and Thrombolysis.

[20]  A. Sule,et al.  Recurrent Unprovoked Venous Thromboembolism in a Young Female Patient with High Levels of Homocysteine , 2012, International Journal of Angiology.

[21]  J. Lantos,et al.  Effect of N-acetylcysteine treatment on the expression of leukocyte surface markers after burn injury. , 2011, Burns : journal of the International Society for Burn Injuries.

[22]  U. Markert,et al.  Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages , 2011, Inflammation Research.

[23]  E. Tremoli,et al.  Homocysteine and arterial thrombosis: Challenge and opportunity , 2010, Thrombosis and Haemostasis.

[24]  S. Theocharis,et al.  The neuroprotective role of l-cysteine towards the effects of short-term exposure to lanthanum on the adult rat brain antioxidant status and the activities of acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase , 2009, BioMetals.

[25]  Dindagur Nagaraja,et al.  Homocysteine, folate and vitamin B12 in puerperal cerebral venous thrombosis , 2008, Journal of the Neurological Sciences.

[26]  F. Sofi,et al.  Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. , 2008, Atherosclerosis.

[27]  S. Eichinger,et al.  Low vitamin B6 levels and the risk of recurrent venous thromboembolism , 2007, Haematologica.

[28]  S. Kaul,et al.  Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. , 2006, Journal of the American College of Cardiology.

[29]  R. Castro,et al.  Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: An overview , 2006, Journal of Inherited Metabolic Disease.

[30]  C. Leitzmann,et al.  German Vegan Study: Diet, Life-Style Factors, and Cardiovascular Risk Profile , 2005, Annals of Nutrition and Metabolism.

[31]  M. Ribó,et al.  Low levels of vitamin B12 and venous thromboembolic disease in elderly men , 2005, Journal of internal medicine.

[32]  S. Lentz Mechanisms of homocysteine‐induced atherothrombosis , 2005, Journal of thrombosis and haemostasis : JTH.

[33]  H. Büller,et al.  Homocysteine and markers of coagulation and endothelial cell activation , 2004, Journal of thrombosis and haemostasis : JTH.

[34]  I. Rosenberg,et al.  The atherogenic effect of excess methionine intake , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Szklo,et al.  Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study. , 2002, Annals of epidemiology.

[36]  Y. Ozkan,et al.  Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. , 2002, International journal of cardiology.

[37]  M. Mora,et al.  Antioxidant and Pro-oxidant Effect of the Thiolic Compounds N -acetyl- l -cysteine and Glutathione against Free Radical-induced Lipid Peroxidation , 2002, Free radical research.

[38]  E. Falk,et al.  Dietary Supplementation With Methionine and Homocysteine Promotes Early Atherosclerosis but Not Plaque Rupture in ApoE-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[39]  S. Vollset,et al.  Plasma Total Cysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project , 2001, Circulation.

[40]  W. Kisiel,et al.  Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. , 2001, The Journal of clinical investigation.

[41]  M. C. Liu,et al.  Blood glutathione and cysteine changes in cardiovascular disease. , 2000, The Journal of laboratory and clinical medicine.

[42]  S. Vollset,et al.  Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. , 1999, The American journal of clinical nutrition.

[43]  P. Giral,et al.  Cysteine is a cardiovascular risk factor in hyperlipidemic patients. , 1999, Atherosclerosis.

[44]  R. Marfella,et al.  Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. , 1999, JAMA.

[45]  D. Jacobsen Homocysteine and vitamins in cardiovascular disease. , 1998, Clinical chemistry.

[46]  J. Selhub,et al.  Homocysteine and thrombotic disease , 1997 .

[47]  P. Ueland,et al.  Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system. , 1996, The Journal of nutrition.

[48]  P. Ueland Homocysteine species as components of plasma redox thiol status. , 1995, Clinical chemistry.

[49]  P. Lønning,et al.  Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[50]  G. Rodgers,et al.  Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[51]  E. Elstner,et al.  Biochemical Model Reactions on the Prooxidative Activity of Homocysteine , 1993, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[52]  J. Sadler,et al.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.

[53]  D. Wilcken,et al.  Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. , 1991, Atherosclerosis.

[54]  G. Starkebaum,et al.  Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. , 1986, The Journal of clinical investigation.

[55]  J. V. Bannister,et al.  The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes. , 1982, Biochimica et biophysica acta.

[56]  D. Wilcken,et al.  The pathogenesis of coronary artery disease. A possible role for methionine metabolism. , 1976, The Journal of clinical investigation.

[57]  J. Bancroft,et al.  Connective Tissues and Stains , 2008 .

[58]  G. Maurer,et al.  Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction. , 2007, Thrombosis research.

[59]  M. Stanton,et al.  Homocysteine and cardiovascular disease , 2011 .